Healthcare Stocks Rise Amid M&A Activity

Dow Jones05:41

Stocks of healthcare companies were the top gainers Thursday amid M&A activity while investors seek less volatile options.

Germany's Merck KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne for $11.3 billion, in an early move under its new chief executive to bulk up its lab-tools business. The proposed acquisition represents Merck's biggest deal since its $17 billion buyout of Sigma-Aldrich more than a decade ago and comes weeks after the appointment of Kai Beckmann as CEO.

Tech investor Prosus said it is investing in France's Alan, a company that built a healthcare platform powered by artificial intelligence, in a deal that values the health insurer at $6.25 billion.

Write to Patrick Sullivan at patrick.sullivan@wsj.com

(END) Dow Jones Newswires

June 25, 2026 17:41 ET (21:41 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646897113?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646897113","market":"nz","top_or_hot":-1,"title":"Healthcare Stocks Rise Amid M&A Activity","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Stocks of healthcare companies were the top gainers Thursday amid M&amp;A activity while investors seek less volatile options. \n</p>\n<p>\n  Germany's <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a> said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne for $11.3 billion, in an early move under its new chief executive to bulk up its lab-tools business. The proposed acquisition represents Merck's biggest deal since its $17 billion buyout of Sigma-Aldrich more than a decade ago and comes weeks after the appointment of Kai Beckmann as CEO. \n</p>\n<p>\n  Tech investor Prosus said it is investing in France's Alan, a company that built a healthcare platform powered by artificial intelligence, in a deal that values the health insurer at $6.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Patrick Sullivan at patrick.sullivan@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 25, 2026 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare Stocks Rise Amid M&A Activity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare Stocks Rise Amid M&A Activity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-26 05:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Stocks of healthcare companies were the top gainers Thursday amid M&amp;A activity while investors seek less volatile options. \n</p>\n<p>\n  Germany's <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a> said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne for $11.3 billion, in an early move under its new chief executive to bulk up its lab-tools business. The proposed acquisition represents Merck's biggest deal since its $17 billion buyout of Sigma-Aldrich more than a decade ago and comes weeks after the appointment of Kai Beckmann as CEO. \n</p>\n<p>\n  Tech investor Prosus said it is investing in France's Alan, a company that built a healthcare platform powered by artificial intelligence, in a deal that values the health insurer at $6.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Patrick Sullivan at patrick.sullivan@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 25, 2026 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2646897113","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2646897113","pubTimestamp":1782423660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Stocks of healthcare companies were the top gainers Thursday amid M&A activity while investors seek less volatile options.Germany's Merck KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne for $11.3 billion, in an early move under its new chief executive to bulk up its lab-tools business. The proposed acquisition represents Merck's biggest deal since its $17 billion buyout of Sigma-Aldrich more than a decade ago and comes weeks after the appointment of Kai Beckmann as CEO.Tech investor Prosus said it is investing in France's Alan, a company that built a healthcare platform powered by artificial intelligence, in a deal that values the health insurer at $6.25 billion.Write to Patrick Sullivan at patrick.sullivan@wsj.com Dow Jones NewswiresJune 25, 2026 17:41 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK4581":"高盛持仓","HCSG":"Healthcare Svcs Group Inc","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XLV":"健康照护类股ETF-SPDR","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LABU":"三倍做多标普生物-Direxion","BK4137":"综合支持服务"},"translate_title":"医疗保健股在并购活动中上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"HCSG":1.5,"XLV":1.5,"XBI":0.6},"content_text":"Stocks of healthcare companies were the top gainers Thursday amid M&A activity while investors seek less volatile options. \n\n\n  Germany's Merck KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne for $11.3 billion, in an early move under its new chief executive to bulk up its lab-tools business. The proposed acquisition represents Merck's biggest deal since its $17 billion buyout of Sigma-Aldrich more than a decade ago and comes weeks after the appointment of Kai Beckmann as CEO. \n\n\n  Tech investor Prosus said it is investing in France's Alan, a company that built a healthcare platform powered by artificial intelligence, in a deal that values the health insurer at $6.25 billion. \n\n\n \n\n\n  Write to Patrick Sullivan at patrick.sullivan@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  June 25, 2026 17:41 ET (21:41 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646897113","isCrawlerRequest":true}